Maria Giulia Nanni1, Rosangela Caruso1, Luzia Travado2, Cidalia Ventura3, Alessandra Palma4, Alejandra M Berardi5, Elena Meggiolaro5, Federica Ruffilli5, Cristina Martins3, David Kissane6, Luigi Grassi1. 1. Institute of Psychiatry, Department of Biomedical and Specialty Surgical Sciences, University of Ferrara, Ferrara, Italy. 2. Psycho-oncology Service, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal. 3. Unidade de Psicologia Clínica, Centro Hospitalar de Lisboa Central, Lisbon, Portugal. 4. Fondazione Sabir, Palermo, Italy. 5. Psycho-Oncology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. 6. Department of Psychiatry, Monash University and Szalmuk Family Research Unit at Cabrini Health, Victoria, Australia.
Abstract
BACKGROUND: Demoralization syndrome is a significant condition that has not been greatly studied in Southern European countries. AIMS: To extend the knowledge of demoralization in Southern Europe by examining its prevalence according to different methods of assessment, its relationship with anxiety and depression, and its impact on quality of life (QoL) among cancer patients. METHODS: A convenience sample of 195 cancer outpatients from two oncology centers (102 from Lisbon, Portugal, and 93 from Ferrara, Italy) participated in an observational, cross-sectional study using the Diagnostic Criteria of Psychosomatic Research-Demoralization interview (DCPR/D) and psychometric tools (Demoralization scale-DS; Patient Health Questionnaire-9/PHQ-9; Hospital Anxiety Depression Scale-HADS; and European Quality of Life-5-EQ-5D). RESULTS: A 25.1% prevalence (CI 95%, 0.19-0.31) of clinically relevant demoralization was reported on the DCPR/D interview. A total demoralization score cutoff score ≥ 25 maximized sensitivity (81.6%), and specificity (72.6%) in identifying DCPR/D demoralized patients. The DCPR/D and DS were associated with poorer levels of QoL. About half of the patients who were demoralized were not clinically depressed (PHQ-9). Self-reported suicidal ideation (PHQ-9 item 9) was found in a minority of patients (8.2%), most of whom (77%) were cases of depression (PHQ-9), but one-quarter (23%) were not depressed, yet moderately/severely demoralized (DCPR/D and DS). CONCLUSIONS: This Southern European study confirms the importance of demoralization in cancer patients as a different condition with respect to depression and its relationship with poor QoL and suicidal ideation.
BACKGROUND:Demoralization syndrome is a significant condition that has not been greatly studied in Southern European countries. AIMS: To extend the knowledge of demoralization in Southern Europe by examining its prevalence according to different methods of assessment, its relationship with anxiety and depression, and its impact on quality of life (QoL) among cancerpatients. METHODS: A convenience sample of 195 cancer outpatients from two oncology centers (102 from Lisbon, Portugal, and 93 from Ferrara, Italy) participated in an observational, cross-sectional study using the Diagnostic Criteria of Psychosomatic Research-Demoralization interview (DCPR/D) and psychometric tools (Demoralization scale-DS; Patient Health Questionnaire-9/PHQ-9; Hospital Anxiety Depression Scale-HADS; and European Quality of Life-5-EQ-5D). RESULTS: A 25.1% prevalence (CI 95%, 0.19-0.31) of clinically relevant demoralization was reported on the DCPR/D interview. A total demoralization score cutoff score ≥ 25 maximized sensitivity (81.6%), and specificity (72.6%) in identifying DCPR/D demoralized patients. The DCPR/D and DS were associated with poorer levels of QoL. About half of the patients who were demoralized were not clinically depressed (PHQ-9). Self-reported suicidal ideation (PHQ-9 item 9) was found in a minority of patients (8.2%), most of whom (77%) were cases of depression (PHQ-9), but one-quarter (23%) were not depressed, yet moderately/severely demoralized (DCPR/D and DS). CONCLUSIONS: This Southern European study confirms the importance of demoralization in cancerpatients as a different condition with respect to depression and its relationship with poor QoL and suicidal ideation.
Authors: Cristiano Scandurra; Francesco Mangiapia; Roberto La Rocca; Francesco Di Bello; Natascia De Lucia; Benedetta Muzii; Micaela Cantone; Rita Zampi; Gianluigi Califano; Nelson Mauro Maldonato; Nicola Longo Journal: Support Care Cancer Date: 2022-05-18 Impact factor: 3.359
Authors: Brian T Anderson; Alicia Danforth; Prof Robert Daroff; Christopher Stauffer; Eve Ekman; Gabrielle Agin-Liebes; Alexander Trope; Matthew Tyler Boden; Prof James Dilley; Jennifer Mitchell; Joshua Woolley Journal: EClinicalMedicine Date: 2020-09-24
Authors: Alessandra Costanza; Michalina Radomska; Francesco Zenga; Andrea Amerio; Andrea Aguglia; Gianluca Serafini; Mario Amore; Isabella Berardelli; Yasutaka Ojio; Khoa D Nguyen Journal: Int J Environ Res Public Health Date: 2021-01-20 Impact factor: 3.390
Authors: Susan Koranyi; Andreas Hinz; Julia M Hufeld; Tim J Hartung; Leonhard Quintero Garzón; Uta Fendel; Anne Letsch; Matthias Rose; Peter Esser; Anja Mehnert-Theuerkauf Journal: Front Psychol Date: 2021-11-24
Authors: Ting-Gang Chang; Chih-Chiang Hung; Pei-Ching Huang; Chiann-Yi Hsu; Ting-Ting Yen Journal: Int J Environ Res Public Health Date: 2022-10-06 Impact factor: 4.614